 | VTv Therapeutics (VTVT) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 5 at 9:52 PM |
| vTv Therapeutics Announces 2021 First Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - May 5 at 4:48 PM |
 | Short Interest in vTv Therapeutics Inc. (NASDAQ:VTVT) Rises By 138.2%
americanbankingnews.com - April 29 at 1:28 AM |
| Contrasting MusclePharm (OTCMKTS:MSLP) and vTv Therapeutics (NASDAQ:VTVT)
americanbankingnews.com - April 25 at 10:16 PM |
| vTv Therapeutics Stock Is Believed To Be Significantly Overvalued
ca.finance.yahoo.com - April 15 at 11:00 PM |
| vTv Therapeutics (VTVT) Gets Breakthrough Tag for Diabetes Drug
finance.yahoo.com - April 14 at 1:09 PM |
 | Analyzing The Price Action In vTv Therapeutics Stock Today
benzinga.com - April 13 at 12:07 PM |
| TTP399 SimpliciT-1 Study Results to be presented at a scientific symposium in celebration of the 100th anniversary of the discovery of insulin
benzinga.com - April 12 at 4:48 PM |
| vTv Therapeutics Announces Issuance of U.S. Patent Covering Methods of Treatment Using TTP399
finance.yahoo.com - March 23 at 11:43 AM |
 | VTv Drop on New Product Developments
baystreet.ca - March 19 at 1:30 PM |
|
 | The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs
markets.businessinsider.com - March 19 at 8:30 AM |
| vTv Therapeutics Announces Initiation of Study Evaluating TTP399’s Potential to Reduce Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes
finance.yahoo.com - March 19 at 3:29 AM |
| vTv Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 8 at 6:04 PM |
| How Much Are vTv Therapeutics Inc. (NASDAQ:VTVT) Insiders Spending On Buying Shares?
finance.yahoo.com - March 3 at 3:26 PM |
| vTv Therapeutics Announces 2020 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
finance.yahoo.com - February 24 at 6:26 PM |
| vTv Therapeutics Announces Publication in Diabetes Care of Results from SimpliciT-1 Study of TTP399 in Patients with Type 1 Diabetes
finance.yahoo.com - February 23 at 12:59 PM |
| vTv Therapeutics Announces Initiation of Multiple Ascending Dose Study of HPP737, an Oral PDE4 Inhibitor for the Treatment of Psoriasis
finance.yahoo.com - February 17 at 8:53 PM |
| vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually
finance.yahoo.com - January 6 at 5:24 PM |
 | vTv Therapeutics Inc. (NASDAQ:VTVT) Files An 8-K Unregistered Sales of Equity Securities
marketwatch.com - December 18 at 12:41 AM |
| vTv Therapeutics Announces Topline Results of Phase 2 Elevage Study of Azeliragon in Patients with Mild Alzheimer's Disease and Type 2 Diabetes
benzinga.com - December 15 at 7:52 PM |
| vTv Therapeutics Inc. (NASDAQ:VTVT) Files An 8-K Entry into a Material Definitive Agreement
marketwatch.com - December 15 at 7:52 PM |
| vTv Therapeutics Announces Topline Results of Phase 2 Elevage Study of Azeliragon in Patients with Mild Alzheimer’s Disease and Type 2 Diabetes
finance.yahoo.com - December 15 at 7:52 PM |
| vTv Therapeutics Announces Licensing Agreement for Novel Nrf2 Activator to Anteris Bio
finance.yahoo.com - December 15 at 9:52 AM |
| Aditum Bio Announces Formation of Third Company, Anteris Bio
finance.yahoo.com - December 15 at 9:52 AM |
| Mid-Afternoon Market Update: Dow Turns Higher; Nabriva Therapeutics Shares Slide
benzinga.com - December 11 at 3:35 PM |
| Why vTv Therapeutics's Stock is Trading Higher Today
benzinga.com - December 11 at 3:35 PM |
 | Stock Alert: VTv Therapeutics Nearly Doubles On Investment By MacAndrews & Forbes
nasdaq.com - December 11 at 3:35 PM |
| vTv Therapeutics' (VTVT) Shares March Higher, Can It Continue?
finance.yahoo.com - December 2 at 5:23 PM |
|
| Where Do Hedge Funds Stand On vTv Therapeutics Inc (VTVT)?
finance.yahoo.com - November 28 at 10:57 PM |
 | vTv Therapeutics raises $47M via stock purchase agreement
seekingalpha.com - November 24 at 10:42 PM |
| vTv Therapeutics Announces Common Stock Purchase Agreement for up to $47 Million with Lincoln Park Capital
finance.yahoo.com - November 24 at 5:42 PM |
| News for vTv Therapeutics Inc (A)
markets.businessinsider.com - November 18 at 1:07 PM |
| vTv Therapeutics Announces 2020 Third Quarter Financial Results and Update
finance.yahoo.com - November 5 at 6:13 PM |
| VTv Therapeutics' Elevage study suggests comparability to diabetes subgroup of Phase 3 STEADFAST study
seekingalpha.com - November 4 at 9:27 AM |
| vTv Therapeutics Presents Baseline Characteristics of the Enrolled Subjects in the Elevage Study Suggesting Comparability to the Post-Hoc Diabetes Subgroup of the Phase 3 STEADFAST Study
finance.yahoo.com - November 4 at 9:26 AM |
| Week Ahead In Pharma: COVID-19 Data Readout, FDA Decisions, CTAD Presentation
nasdaq.com - November 1 at 7:36 AM |
| What Kind Of Shareholders Hold The Majority In vTv Therapeutics Inc.'s (NASDAQ:VTVT) Shares?
finance.yahoo.com - October 29 at 2:55 PM |
| vTv Therapeutics to Present Study Update and Preliminary Data on Baseline Characteristics of Study Participants in Phase 2 Elevage Study Evaluating Azeliragon at 13th Clinical Trials on Alzheimer’s Disease (CTAD) Digital Event
finance.yahoo.com - October 29 at 8:26 AM |
 | Board member resigns from High Point-based vTv Therapeutics after one month
bizjournals.com - October 9 at 9:53 AM |
| vTv Therapeutics Presents Additional Positive Clinical Study Results Supporting the Safety and Efficacy of TTP399 as Adjunctive Therapy in Patients with Type 1 Diabetes
benzinga.com - September 23 at 7:45 AM |
| vTv Therapeutics adds MacAndrews & Forbes EVP to board
bizjournals.com - September 18 at 8:41 AM |
| An In-Depth Look At vTv Therapeutics
seekingalpha.com - September 16 at 4:04 PM |
| vTv Therapeutics to Present Additional Positive Clinical Study Results from Phase 2 Simplici-T1 Study of TTP399 as Adjunctive Therapy for Patients with Type 1 Diabetes at EASD Virtual Meeting
finance.yahoo.com - September 16 at 11:02 AM |
| vTv Therapeutics Announces Appointment of Edward P. Taibi to its Board of Directors
finance.yahoo.com - September 15 at 12:17 PM |
| vTv Therapeutics Inc. Class A Common Stock (VTVT)
nasdaq.com - August 17 at 9:37 PM |
| vTv Therapeutics Announces 2020 Second Quarter Financial Results and Update
finance.yahoo.com - August 3 at 6:25 PM |
| vTv Therapeutics to Present Additional Clinical Data from the STEADFAST Study of Azeliragon at the Virtual Alzheimer's Association International Conference
finance.yahoo.com - July 27 at 9:03 AM |
| vTv Therapeutics' TTP399 successful in mid-stage type 1 diabetes study
seekingalpha.com - June 15 at 9:33 AM |
| vTv Therapeutics Presents Two Late-Breaking Poster Sessions on Simplici-T1 Study at the American Diabetes Association’s Virtual Sessions Supporting the Potential of TTP399 as First-in-Class Oral Adjunctive Therapy for Type 1 Diabetes Patients
finance.yahoo.com - June 13 at 12:46 PM |
| vTv Therapeutics Presents Two Late-Breaking Poster Sessions on Simplici-T1 Study at the American Diabetes Association's Virtual Sessions Supporting the Potential of TTP399 as First-in-Class Oral Adjunctive Therapy for Type 1 Diabetes Patients
www.benzinga.com - June 13 at 12:36 PM |
